Toward evidence-grounded AI systems for medication safety

Polypharmacy requires drug–drug interaction risk to be assessed in relation to mechanism, severity, patient vulnerability, exposure, monitoring options, and clinical workflow. Feature-based methods, deep learning, knowledge graphs, multimodal fusion, and event-level models provide a computational foundation for predicting DDIs. Their clinical application also requires patient-specific interpretation and evaluation within the intended workflow. This narrative review examines how pairwise prediction can be integrated with these requirements in medication-safety systems. Multimodal biomedical foundation models may connect chemical structures, targets, pathways, knowledge graphs, literature, pharmacovigilance, real-world evidence, and patient trajectories. Large language models can assist with retrieval, summarization, explanation, and communication under source verification and professional review. Bounded AI agents may coordinate planning, tool use, verification, escalation, documentation, monitoring, and audit. We organize these components into a human-supervised architecture and an evaluation pathway linking model performance with workflow and clinical outcomes. Key challenges include data leakage, distribution shift, poorly documented evidence sources, hallucination, workflow burden, governance, and limited prospective validation. Prospective evaluations should assess how these systems affect medication decisions, monitoring, and patient outcomes, alongside the reliability of their evidence and the workload they create.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-20
DOI
https://doi.org/10.3389/fphar.2026.1949488
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Toward evidence-grounded AI systems for medication safety

Yiming Chen, Lei Wang, Zhen Zhang, Xianjun Hu et al.
2 links
Frontiers in Pharmacology
Pharmaceutical Practices and Patient Outcomes
article

Toward evidence-grounded AI systems for medication safety

Yiming Chen, Lei Wang, Zhen Zhang, Xianjun Hu, Tianyu Li, Jiayi Zhou
article en

Abstract

Polypharmacy requires drug–drug interaction risk to be assessed in relation to mechanism, severity, patient vulnerability, exposure, monitoring options, and clinical workflow. Feature-based methods, deep learning, knowledge graphs, multimodal fusion, and event-level models provide a computational foundation for predicting DDIs. Their clinical application also requires patient-specific interpretation and evaluation within the intended workflow. This narrative review examines how pairwise prediction can be integrated with these requirements in medication-safety systems. Multimodal biomedical foundation models may connect chemical structures, targets, pathways, knowledge graphs, literature, pharmacovigilance, real-world evidence, and patient trajectories. Large language models can assist with retrieval, summarization, explanation, and communication under source verification and professional review. Bounded AI agents may coordinate planning, tool use, verification, escalation, documentation, monitoring, and audit. We organize these components into a human-supervised architecture and an evaluation pathway linking model performance with workflow and clinical outcomes. Key challenges include data leakage, distribution shift, poorly documented evidence sources, hallucination, workflow burden, governance, and limited prospective validation. Prospective evaluations should assess how these systems affect medication decisions, monitoring, and patient outcomes, alongside the reliability of their evidence and the workload they create.

Frontiers in PharmacologyVol. 17
Jishou University (CN), Changsha University (CN)
National Natural Science Foundation of China
Good health and well-being
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Toward evidence-grounded AI systems for medication safety — Yiming Chen, Lei Wang, et al. · Frontiers in Pharmacology (2026) | TGRS Research Map | TGRS